[podcast]FDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels

[cafead]

via FDA paused many of its in-person inspection efforts during COVID-19 because of travel disruptions and safety concerns. So now that COVID is over, are inspections back to normal?

article source